American physician
Johanna Olson-Kennedy is an American physician who specializes in the care of children and teenagers with gender dysphoria and youth with HIV and chronic pain. She is board-certified in pediatrics and adolescent medicine and is the medical director of the Center for Transyouth Health and Development at Children's Hospital Los Angeles.
Olson-Kennedy has co-authored multiple studies on transgender youth. She also has been interviewed for multiple news pieces, has served as a frequent expert witness in court cases, and as of 2024 is the president-elect of the United States Professional Association for Transgender Health (USPATH).
Biography.
Olson-Kennedy is the co-author of multiple of studies on transgender youth. These include studies on chest reconstruction, gender identity development, physiological responses to gender-affirming hormones, and the use of puberty blockers. She is a critic of a "gatekeeping" approach to youth gender medicine, according to "The Economist".
In 2012, Olson-Kennedy became the medical director of the Center for Transyouth Health and Development at Children’s Hospital Los Angeles, the largest transgender youth clinic in the United States as of 2024. In 2015, she began to lead a $10 million NIH-funded research project to study youth gender medicine, described as "by far the largest such project in America" by "The Economist".
In October 2024, the "New York Times" reported that Olson-Kennedy elected not to publish a long-running study on puberty blockers funded by the National Institutes of Health, which showed that blockers did not lead to improvements in mental health of children. Olson-Kennedy said this was likely because the children in the study were doing well when the study began. She said she was concerned that the study's results could be used by political opponents in the US to argue in court that "we shouldn't use blockers because it doesn't impact [transgender adolescents]". As summarized by the "New York Times", other researchers involved in the study, including Amy Tishelman, were "alarmed by the idea of delaying results that would have immediate implications for families around the world." However, other studies from the larger NIH project have been published, including one that found "improvements in life and body satisfaction" in transgender and nonbinary adolescents who took estrogen or testosterone as well as "declines in depression and anxiety."
In December 2024, Olson-Kennedy was sued by a 20-year old female detransitioner, alleging she had caused permanent harm by a rushed diagnosis of gender dysphoria "mere minutes" after first seeing the plaintiff at age 12, who went on to receive puberty blockers, testosterone, and a double mastectomy at age 14. The lawsuit also names the St. Francis Hospital in San Francisco and a second doctor as defendants, alleging that the latter had "rubber-stamped" the mastectomy.
The same day, a group of Republican senators published a letter addressed to the director of the NIH which inquired further information about the NIH project and reiterated the importance of transparency in the medical research that the NIH supports with public funds. All senators involved except for one had previously sponsored a ban on youth gender-affirming care. This letter follows an earlier November 4th letter from the House Committee on Oversight and Accountability to the director whose focal point was again the unpublished study by Johanna Olson-Kennedy.
References.
 ;templatestyles src="Reflist/styles.css" / ;